---
title: Chronic Low Back Pain - Epiduroscopy Treatment
nct_id: NCT03916666
overall_status: UNKNOWN
sponsor: Pavol Jozef Safarik University
study_type: OBSERVATIONAL
primary_condition: Chronic Low Back Pain
countries: Czechia, Slovakia
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03916666.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03916666"
ct_last_update_post_date: 2020-06-11
last_seen_at: "2026-05-12T07:08:16.185Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Chronic Low Back Pain - Epiduroscopy Treatment

**NCT ID:** [NCT03916666](https://clinicaltrials.gov/study/NCT03916666)

## Key Facts

- **Status:** UNKNOWN
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 150
- **Lead Sponsor:** Pavol Jozef Safarik University
- **Collaborators:** EPC Education s.r.o.
- **Conditions:** Chronic Low Back Pain
- **Start Date:** 2021-12-11
- **Completion Date:** 2021-12-21
- **CT.gov Last Update:** 2020-06-11

## Brief Summary

Retrospective analysis of patients with low back pain after epiduroscopic procedure

## Detailed Description

Retrospective analysis of patients with low back pain after epiduroscopic procedure Retrospective analysis of ambulatory data and next phone survey

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 80 Years
- **Sex:** ALL

```
Inclusion Criteria:

* all patients after epiduroscopy

Exclusion Criteria:

* patients disagreement
```

## Interventions

- **Epiduroscopy** (PROCEDURE) — Endoscopic intervention

## Primary Outcomes

- **Incidence of back pain after epiduroscopic procedure** _(time frame: 1 year)_
- **Incidence of leg pain after epiduroscopic procedure** _(time frame: 1 year)_

## Locations (2)

- EuroPainClinics .z.ú, Prague, Smetanovo Nábřeží 327/14, Czechia — _RECRUITING_
- East Slovak Institute for Cardiovascular Diseases, Košice, Slovakia — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.europainclinics .z.ú|prague|smetanovo nábřeží 327/14|czechia` — added _(2026-05-12)_
- `locations.east slovak institute for cardiovascular diseases|košice||slovakia` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03916666.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03916666*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*